XTX Topco Ltd

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1828301 LONDON, X0

Position in PLRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$631,055

-$33,864 QoQ

Shares Held

500,838

-8.1% QoQ

Ownership

0.809%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $287,762,779 across 374 Biotechnology names. PLRX ranks #124 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	255,431	$7,075,438
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,632	$6,980,313
3	IONS	Ionis Pharmaceuticals Inc	80,519	$6,046,171
4	EXEL	Exelixis, Inc.	134,413	$5,764,973
5	NUVL	Nuvalent, Inc.	53,354	$5,466,117
6	AGIO	Agios Pharmaceuticals, Inc.	160,880	$5,442,570
7	BMRN	Biomarin Pharmaceutical Inc	93,609	$5,287,972
8	RYTM	Rhythm Pharmaceuticals, Inc.	59,502	$5,174,888

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$631,055	500,838	-8.1%	Shares	Defined	2026-05-15
2025-12-31	$664,919	545,016	+16.7%	Shares	Defined	2026-02-17
2025-09-30	$691,136	466,984	+8.9%	Shares	Defined	2025-11-14
2025-06-30	$497,651	429,010	-8.1%	Shares	Defined	2025-08-12
2025-03-31	$630,236	466,842	+3802.4%	Shares	Defined	2025-05-08
2023-09-30	$207,438	11,963	-0.8%	Shares	Defined	2023-11-13
2023-06-30	$218,545	12,061	-13.3%	Shares	Defined	2023-08-14
2022-12-31	$269,034	13,918	-10.7%	Shares	Defined	2023-02-14
2022-06-30	$124,803	15,581	+22.4%	Shares	Defined	2022-08-15
2022-03-31	$89,202	12,725	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.